Buserelin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06719 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 59 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypertrichosis (disease) | KG + DL |
| 2 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 3 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 4 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 5 | isolated genetic hair shaft abnormality | KG + DL |
| 6 | pulmonary hypertension | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | amenorrhea (disease) | KG + DL |
| 9 | familial isolated trichomegaly | KG + DL |
| 10 | genetic alopecia | KG + DL |
| 11 | benign prostatic hyperplasia (disease) | KG + DL |
| 12 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 13 | open-angle glaucoma | KG + DL |
| 14 | primary hereditary glaucoma | KG + DL |
| 15 | precocious puberty | KG + DL |
| 16 | hypotrichosis simplex of the scalp | KG + DL |
| 17 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 18 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 19 | alopecia | KG + DL |
| 20 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 21 | congenital hypotrichosis milia | KG + DL |
| 22 | pseudopelade of Brocq | KG + DL |
| 23 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 24 | diffuse alopecia areata | KG + DL |
| 25 | coxopodopatellar syndrome | KG + DL |
| 26 | migraine disorder | KG + DL |
| 27 | migraine with brainstem aura | KG + DL |
| 28 | pulmonary hypertension, primary | KG + DL |
| 29 | pulmonary arterial hypertension | KG + DL |
| 30 | idiopathic pulmonary arterial hypertension | KG + DL |
| 31 | familial male-limited precocious puberty | KG + DL |
| 32 | Raynaud disease | KG + DL |
| 33 | adrenal gland hyperfunction | KG + DL |
| 34 | aromatase excess syndrome | KG + DL |
| 35 | prostate calculus | KG + DL |
| 36 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 37 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 38 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 39 | subarachnoid hemorrhage (disease) | KG + DL |
| 40 | gastrointestinal hamartoma | KG + DL |
| 41 | persistent Mullerian duct syndrome | KG + DL |
| 42 | glaucoma 1, open angle | KG + DL |
| 43 | acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | KG + DL |
| 44 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 45 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 46 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 47 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 48 | thoracic malformation | KG + DL |
| 49 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 50 | syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy | KG + DL |
(Showing top 50 of 59 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.